Intrinsic subtypes and prognostic implications in epithelial ovarian cancer
Author
Summary, in English
In study I, a gene expression profile differentiating the rare subgroup of Lynch syndrome-associated ovarian cancer from a matched sporadic cohort was identified. The Lynch syndrome-related expression profile was associated with proliferation and cell death processes. An external dataset was used to refine the gene expression profile, but validation with immunohistochemical staining of key proteins did not reveal any differences between the hereditary and sporadic cases. A distinct cluster of hereditary serous and endometrioid cancers was seen, whereas clear cell carcinomas (OCCCs) clustered together, whether hereditary or sporadic. In study II, gene expression profiling of OCCCs revealed extensive inter-tumor heterogeneity. Targeted deep sequencing of 60 cancer-related genes in an OCCC cohort revealed frequent mutations of chromatin remodeling genes, including mutations not previously reported in ovarian cancer. These results remain to be validated.
Study III outlined gene expression profiles in malignant, borderline, and benign serous ovarian tumors. Pre-defined molecular subtypes of ovarian cancer as well as intrinsic breast cancer subtypes were applied to our cohort. Associations between the most aggressive ovarian cancer subtypes and the basal-like breast cancer subtype were identified. The results were validated using a large, external dataset. Furthermore, associations between borderline ovarian tumors and the luminal A breast cancer subtype were discovered. The luminal A breast cancer subtype characterizes hormone receptor positive breast cancer. In study IV, we therefore outlined the protein expression of estrogen receptor (ER) α, ERβ, the progesterone receptor (PR), and the androgen receptor (AR) as well as the prognostic effect of receptor expression in serous and endometrioid ovarian cancer. Expression of PR and AR was associated with a favorable prognosis, and co-expression of PR and AR conferred an additional prognostic benefit. The mRNA levels of the encoding genes were investigated in the molecular subtypes of ovarian cancer using an external dataset. The expression varied between the different subtypes, but no prognostic benefit of dual high PGR and AR levels were revealed.
In conclusion these studies further characterize the ovarian cancer heterogeneity, and support that future ovarian cancer studies need to be stratified for both histopathologic subtypes and molecular features
Department/s
- BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
- Breastcancer-genetics
Publishing year
2015
Language
English
Publication/Series
Lund University Faculty of Medicine Doctoral Dissertation Series
Volume
2016:5
Full text
Document type
Dissertation
Publisher
Division of Oncology and Pathology, Lund University
Topic
- Cancer and Oncology
Keywords
- ovarian cancer
- gene expression profiling
- Lynch syndrome
- targeted deep sequencing
- chromatin remodeling
- molecular subtypes
- endocrine receptors
- prognostic factors
- tumor heterogeneity
Status
Published
ISBN/ISSN/Other
- ISSN: 1652-8220
- ISBN: 978-91-7619-230-6
Defence date
29 January 2016
Defence time
10:00
Defence place
The lecture hall in the Radiotherapy building, Skåne Oncology Clinic, Lund
Opponent
- Joseph Carlson (Associte professor)